IGeneX

IGeneX is a company that has been at the forefront of Lyme disease and other tick-borne related illnesses for over 25 years. The company is dedicated to developing the most advanced tests for tick-borne illnesses and COVID-19, making a profound impact on how these diseases are diagnosed. Not only does IGeneX provide testing diagnostics for more accurate diagnosis, but it also plays a crucial role in training physicians to better understand tick-borne diseases and become Lyme literate. With a commitment to advancing the understanding and diagnosis of these illnesses, IGeneX is positioned as a key player in the healthcare industry, particularly in the area of infectious diseases and diagnostic testing.